- জেনেরিক নাম
- Glimepiride
- শক্তি
- 2 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- UniMed UniHealth
- থেরাপিউটিক ক্লাস
- Sulfonylureas
৳ ৪.৯ ৳ ৫.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
Adglim হলো Glimepiride-এর একটি ব্র্যান্ড, শক্তি ২ mg, ট্যাবলেট আকারে। Glimepiride-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। দাম: প্রতি ইউনিট ৫.০০ টাকা। এটি তৈরি করে UniMed UniHealth। এর থেরাপিউটিক ক্লাস Sulfonylureas। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Glimepiride-এর ৪১টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ৫টি। সবচেয়ে কম দাম Mepid 1 mg Tablet-এর, প্রতি ইউনিট ৳ ২.৫১।
Adglim 2 mg is a tablet product of UniMed UniHealth that contains Glimepiride. It is meant to be used together with diet and exercise, and sometimes with metformin, when these alone do not control blood sugar well enough. It belongs to the sulfonylureas, a group of oral antidiabetic medicines. Always follow your doctor's instructions and keep regular check-ups.
It may also be used together with metformin when diet, exercise and either medicine alone are not enough. It is not suitable for type I diabetes, diabetic ketoacidosis or diabetic coma. Ask your doctor whether it is right for your condition.
Take Adglim 2 mg tablet as the doctor instructs. Adglim is taken by mouth. Swallow the tablet with water. Shake the bottle well before each use. Do not change the dose yourself. The doctor decides the dose, how often to take it, and for how long.
Possible side effects include low blood sugar (hypoglycaemia), temporary vision problems, nausea, vomiting, diarrhoea, abdominal pain, hives, and a fall in blood pressure. If you experience any of these, contact your doctor. Like all medicines, Adglim can cause side effects. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.
Do not take it if you are allergic to Glimepiride, other sulfonylureas, or sulfonamides, or if you have severe liver or kidney problems, or are on dialysis. Do not take it during pregnancy or while breastfeeding; a change to insulin is needed, so tell your doctor if you are pregnant, planning a pregnancy or breastfeeding. Adglim 2 mg tablet must not be used in type I diabetes, diabetic ketoacidosis or diabetic coma, or by people allergic to Glimepiride, other sulfonylureas or other sulfonamides. Ask your doctor before starting or stopping any medicine.
It may also be used together with metformin when diet, exercise and either medicine alone are not enough. It is not suitable for type I diabetes, diabetic ketoacidosis or diabetic coma.
Take Adglim 2 mg tablet as the doctor instructs. Adglim is taken by mouth.
Possible side effects include low blood sugar (hypoglycaemia), temporary vision problems, nausea, vomiting, diarrhoea, abdominal pain, hives, and a fall in blood pressure. If you experience any of these, contact your doctor.
The listed price is ৳ ৫.০০.
৳ ৪.৯ ৳ ৫.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride is indicated in following conditions-এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride is a sulfonylurea antidiabetic agent which decreases blood glucose concentration. The primary mechanism of action of Glimepiride appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells. Glimepiride acts in concert with glucose by improving the sensitivity of beta cells to physiological glucose stimulus, resulting in insulin secretion. In addition, extrapancreatic effects like reduction of basal hepatic glucose production, increased peripheral tissue sensitivity to insulin and glucose uptake may also play role in the activity of Glimepiride. In non-fasting diabetic patients, the hypoglycaemic action of a single dose of Glimepiride persists for 24 hours.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
In principle, the dosage of Glimepiride is governed by the desired blood sugar level. The dosage of Glimepiride must be the lowest which is sufficient to achieve the desired metabolic control. The initial and the maintenance doses are set based on the results of regular check of glucose in blood and urine. Monitoring of glucose levels in blood and urine also serves to detect either primary or secondary failure of therapy.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Based on experience with Glimepiride and known interactions for other sulfonylureas, the following interactions must be considered.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride is not suitable for the treatment of insulin dependent (type I) diabetes mellitus, or for the treatment of diabetic ketoacidosis, nor for the treatment of diabetic coma. Glimepiride must not be used in patients hypersensitive to Glimepiride, other sulfonylureas, other sulfonamides, severe hepatic dysfunction, severe impairment of renal function and dialysis patients.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hypoglycaemia, temporary visual impairment, nausea, vomiting, diarrhoea, abdominal pain, urticaria, fall in blood pressure.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride must not be taken during pregnancy; a changeover to insulin is necessary. Patients planning a pregnancy must inform their physician, and should change over to insulin. Ingestion of Glimepiride with breast milk feeding may harm the child. Therefore, Glimepiride must not be taken by breastfeeding women. Either a changeover or complete discontinuation of breastfeeding is necessary.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
in the initial weeks of treatment, the risk of hypoglycaemia may be increased and necessitates careful monitoring. If such risk present it may be necessary to adjust the dosage of Glimepiride, Hypoglycaemia can almost be promptly controlled by immediate intake of carbohydrates (glucose or sugar).এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Overdosage of sulfonylureas, including Glimepiride, can produce hypoglycaemia. Mild hypoglycaemic symptoms without loss of consciousness or neurologic findings should be treated aggressively with oral glucose and adjustments in drug dosage or meal patterns. Close monitoring should continue until the physician is assured that the patient is out of danger. Severe hypoglycaemic reactions with coma, seizure, or other neurological impairment occur infrequently, but constitute medicai emergencies requiring immediate hospitalization. If hypoglycaemic coma is diagnosed or suspected, the patient should be given a rapid intravenous injection of concentrated (50%) glucose solution. This should be followed by a continuous infusion of a more dilute (10%) glucose solution at a rate that will maintain the blood glucose at a level above 100 mg/dl. Patients should be closely monitored for a minimum of 24 to 48 hours, because hypoglycaemia may recur after apparent clinical recovery.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Do not store above 30°C. Keep away from light and out of the reach of children.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।